Webinar – An Introduction to Neurodegenerative Pathology for Neuropsychologists

Autopsy remains the gold standard for diagnosis of neurodegenerative disease. Neurodegeneration is defined as the progressive loss of selectively vulnerable neurons in specific anatomic networks, thus leading to neuronal death and cognitive impairment. Neurodegenerative diseases are therefore characterized by the clinical phenotype (e.g. a dementia syndrome), anatomic patterns of atrophy or vulnerability, and pathology at […]

Webinar – Cannabis and Neuropsychological Functioning: An Update on Adverse Effects in Adolescence and Beyond

Public sentiment and laws around the use of cannabis continue to become more permissive in the United States alongside a growing perception of effective medicinal applications. Yet, there is a robust literature documenting cannabis-associated worsening of neuropsychological functioning. What does the current scientific research suggest about the type and magnitude of neuropsychological side-effects from recreational […]

Webinar – COVID-19 Teleneuropsychology(TeleNP)

In response to the Coronavirus (COVID-19) outbreak, there is a pressing need for neuropsychology to apply tele-communication technologies to deliver services to patients unable to attend in-person appointments. Encouragingly, new evidence is emerging to support development of novel models of neuropsychology service delivery remotely. Using North America and Australia as examples, this webinar will illustrate […]

Podcast Episode 124 | The Neuropsychology of Addiction – With Dr. Antonio Verdejo-Garcia

This episode is a conversation with Dr. Antonio Verdejo-Garcia about the neuropsychology of addiction. We cover addiction epidemiology, the syndrome model, neurobiology, transdiagnostic constructs such as compulsivity, behavioral addictions, cognitive profiles linked to substances of abuse, and behavioral, pharmacological, and cognitive treatments for people with addictions.

Podcast Episode 122| Parkinson’s Disease – With Dr. Sara Schaefer

This episode is a wide ranging discussion of Parkinson’s disease, with Dr. Sara Schaefer. The conversation begins with basic facts, features, and concepts, and then moves into more complex topics, while covering many critical factors for neuropsychologists to consider. It includes a focus on diagnosis/symptoms, epidemiology, core neuropathology, neurodiagnostic approaches, risk factors (e.g., REM behavior […]

Podcast Episode 116 | Brain Health in Adults – With Dr. Vonetta Dotson

This episode is a broad overview of brain health in adults. We discuss methods for encouraging positive brain health behavior change in our patients, how to help patients who have little to no motivation for change (“precontemplation” stage), the importance of tailoring feedback to a patient’s level of health literacy, research support for various forms […]

Podcast Episode 114 | Loneliness – With Dr. Ellen Lee

In this episode, we discuss loneliness with Dr. Ellen Lee. We cover definitions, epidemiology, various assessment methods (including digital technology), relationships with age, sex/gender, race/ethnicity, and culture, overall physical, cognitive, and mental health effects, and interventions to reduce loneliness.

Podcast Episode 112 | Functional (Nonepileptic) Seizures – With Dr. W. Curt LaFrance Jr.

In this episode, we speak with Dr. W. Curt LaFrance about functional (nonepileptic seizures). We cover epidemiology, overlap and differences with regard to epilepsy, negative health outcomes, co-occurring psychological and neurological factors, an etiological framework, cognitive profiles, and treatment. We also discuss general overlap across neurology and psychiatry, as well as future directions in research […]

Podcast Episode 108 | Functional Neurological Disorders – With Dr. Mark Hallett

In this episode, we speak with Dr. Mark Hallett about functional neurological disorders (FNDs). We cover the history, epidemiology, symptomatology, and pathophysiology of FNDs. We touch on the issue of “lumping versus splitting,” controversies in the literature, the need for better training on FNDs in medicine and psychology, and currently available treatments, among other topics.